Gabapentin Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Gabapentin Market

1.1. Definition and Scope

1.1.1. Definition of Gabapentin

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Gabapentin Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Gabapentin Market By Dosage

1.2.3. Gabapentin Market By Type

1.2.4. Gabapentin Market By Application

1.2.5. Gabapentin Market By Distribution Channel

1.2.6. Gabapentin Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Gabapentin Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Gabapentin Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Gabapentin Market By Dosage

5.1. Introduction

5.2. Gabapentin Revenue By Dosage

5.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Dosage, 2020-2032

5.2.2. Tablet

5.2.2.1. Tablet Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.3. Oral Solution

5.2.3.1. Oral Solution Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

5.2.4. Capsule

5.2.4.1. Capsule Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 6. Gabapentin Market By Type

6.1. Introduction

6.2. Gabapentin Revenue By Type

6.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Type, 2020-2032

6.2.2. Branded

6.2.2.1. Branded Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

6.2.3. Generic

6.2.3.1. Generic Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 7. Gabapentin Market By Application

7.1. Introduction

7.2. Gabapentin Revenue By Application

7.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Application, 2020-2032

7.2.2. Epilepsy

7.2.2.1. Epilepsy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.3. Restless Legs Syndrome

7.2.3.1. Restless Legs Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.4. Neuropathic Pain

7.2.4.1. Neuropathic Pain Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

7.2.5. Others

7.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 8. Gabapentin Market By Distribution Channel

8.1. Introduction

8.2. Gabapentin Revenue By Distribution Channel

8.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032

8.2.2. Hospital Pharmacy

8.2.2.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.3. Online Pharmacy

8.2.3.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

8.2.4. Retail Pharmacy

8.2.4.1. Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032

CHAPTER 9. North America Gabapentin Market By Country 

9.1. North America Gabapentin Market Overview

9.2. U.S.

9.2.1. U.S. Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

9.2.2. U.S. Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

9.2.3. U.S. Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

9.2.4. U.S. Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.3. Canada

9.3.1. Canada Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

9.3.2. Canada Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

9.3.3. Canada Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

9.3.4. Canada Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

9.4. North America PEST Analysis

CHAPTER 10. Europe Gabapentin Market By Country

10.1. Europe Gabapentin Market Overview

10.2. U.K.

10.2.1. U.K. Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

10.2.2. U.K. Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

10.2.3. U.K. Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

10.2.4. U.K. Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.3. Germany

10.3.1. Germany Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

10.3.2. Germany Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

10.3.3. Germany Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

10.3.4. Germany Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.4. France

10.4.1. France Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

10.4.2. France Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

10.4.3. France Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

10.4.4. France Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.5. Spain

10.5.1. Spain Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

10.5.2. Spain Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

10.5.3. Spain Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

10.5.4. Spain Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.6. Rest of Europe

10.6.1. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

10.6.2. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

10.6.3. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

10.6.4. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

10.7. Europe PEST Analysis

CHAPTER 11. Asia Pacific Gabapentin Market By Country

11.1. Asia Pacific Gabapentin Market Overview

11.2. China

11.2.1. China Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

11.2.2. China Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

11.2.3. China Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

11.2.4. China Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.3. Japan

11.3.1. Japan Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

11.3.2. Japan Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

11.3.3. Japan Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

11.3.4. Japan Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.4. India

11.4.1. India Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

11.4.2. India Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

11.4.3. India Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

11.4.4. India Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.5. Australia

11.5.1. Australia Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

11.5.2. Australia Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

11.5.3. Australia Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

11.5.4. Australia Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.6. South Korea

11.6.1. South Korea Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

11.6.2. South Korea Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

11.6.3. South Korea Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

11.6.4. South Korea Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

11.7.2. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

11.7.3. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

11.7.4. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

11.8. Asia Pacific PEST Analysis

CHAPTER 12. Latin America Gabapentin Market By Country

12.1. Latin America Gabapentin Market Overview

12.2. Brazil

12.2.1. Brazil Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

12.2.2. Brazil Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

12.2.3. Brazil Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

12.2.4. Brazil Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.3. Mexico

12.3.1. Mexico Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

12.3.2. Mexico Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

12.3.3. Mexico Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

12.3.4. Mexico Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.4. Rest of Latin America

12.4.1. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

12.4.2. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

12.4.3. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

12.4.4. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

12.5. Latin America PEST Analysis

CHAPTER 13. Middle East & Africa Gabapentin Market By Country 

13.1. Middle East & Africa Gabapentin Market Overview

13.2. GCC

13.2.1. GCC Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

13.2.2. GCC Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

13.2.3. GCC Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

13.2.4. GCC Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

13.3. South Africa

13.3.1. South Africa Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

13.3.2. South Africa Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

13.3.3. South Africa Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

13.3.4. South Africa Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032

13.4.2. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032

13.4.3. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032

13.4.4. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032

13.5. Middle East & Africa PEST Analysis

CHAPTER 14. Player Analysis Of Gabapentin Market

14.1. Gabapentin Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

14.2.2. New ProductLaunches and Product Enhancements

14.2.3. Mergers And Acquisition In Global Gabapentin Market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 15. Company Profile

15.1. Pfizer Inc.

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (USD Billion), 2022

15.1.3.2. Pfizer Inc. 2022 Gabapentin Business Regional Distribution

15.1.4. Product/Service and Specification

15.1.5. Recent Developments & Business Strategy

15.2. Mylan N.V.

15.3. Aurobindo Pharma Ltd.

15.4. Teva Pharmaceutical Industries Ltd.

15.5. Lupin Limited

15.6. Sun Pharmaceutical Industries Ltd.

15.7. Novartis AG

15.8. Cadila Healthcare Ltd. (Zydus Cadila)

15.9. Torrent Pharmaceuticals Ltd.

15.10. Dr. Reddy's Laboratories Ltd.

15.11. Sandoz International GmbH

15.12. Apotex Inc.